TY - JOUR
T1 - Neurohormonal therapy for congestive heart failure
AU - Pritchett, Allison M.
AU - Mann, Douglas L.
PY - 2004/12
Y1 - 2004/12
N2 - Guidelines for heart failure management have been published by the American College of Cardiology and the American Heart Association in 2001. These guidelines recommend the use of angiotensin-converting enzyme inhibitors and β blockers to improve the symptoms and prognosis of heart failure. Despite being advocated as the cornerstone of medical management, these agents remain underutilized. Not only are these drugs underutilized, but titration to dosages with proven beneficial effects is lacking. Simply achieving widespread usage of these agents would have a significant impact on heart failure outcomes.
AB - Guidelines for heart failure management have been published by the American College of Cardiology and the American Heart Association in 2001. These guidelines recommend the use of angiotensin-converting enzyme inhibitors and β blockers to improve the symptoms and prognosis of heart failure. Despite being advocated as the cornerstone of medical management, these agents remain underutilized. Not only are these drugs underutilized, but titration to dosages with proven beneficial effects is lacking. Simply achieving widespread usage of these agents would have a significant impact on heart failure outcomes.
UR - http://www.scopus.com/inward/record.url?scp=10144256511&partnerID=8YFLogxK
U2 - 10.1007/s11936-004-0007-6
DO - 10.1007/s11936-004-0007-6
M3 - Review article
C2 - 15496267
AN - SCOPUS:10144256511
SN - 1092-8464
VL - 6
SP - 499
EP - 507
JO - Current Treatment Options in Cardiovascular Medicine
JF - Current Treatment Options in Cardiovascular Medicine
IS - 6
ER -